Abstract
β-catenin is a central molecule in the Wnt pathway. Expression of a stable form of β-catenin on CD4+CD25+ regulatory T (Treg) cells resulted in a marked enhancement of survival of these cells in vitro. Furthermore, stable β-catenin–expressing CD4+CD25+ Treg cells outcompeted control Treg cells in vivo, and the number of Treg cells necessary for protection against inflammatory bowel disease could be substantially reduced when stable β-catenin–expressing CD4+CD25+ Treg cells were used instead of control Treg cells. Expression of stable β-catenin on potentially pathogenic CD4+CD25− T cells rendered these cells anergic, and the β-catenin–mediated induction of anergy occurred even in Foxp3-deficient T cells. Thus, through enhanced survival of existing regulatory T cells, and through induction of unresponsiveness in precursors of T effector cells, β-catenin stabilization has a powerful effect on the prevention of inflammatory disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro
Scientific Reports Open Access 18 March 2019
-
Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination
Scientific Reports Open Access 30 August 2018
-
Cbl-b deficiency provides protection against UVB-induced skin damage by modulating inflammatory gene signature
Cell Death & Disease Open Access 06 August 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Gregorieff, A. & Clevers, H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 19, 877–890 (2005).
Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843–850 (2005).
Willert, K. & Jones, K.A. Wnt signaling: is the party in the nucleus? Genes Dev. 20, 1394–1404 (2006).
Amit, S. et al. Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 16, 1066–1076 (2002).
Liu, C. et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837–847 (2002).
Jiang, J. & Struhl, G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391, 493–496 (1998).
Latres, E., Chiaur, D.S. & Pagano, M. The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene 18, 849–854 (1999).
Staal, F.J., Noort Mv, M., Strous, G.J. & Clevers, H.C. Wnt signals are transmitted through N-terminally dephosphorylated β-catenin. EMBO Rep. 3, 63–68 (2002).
Curotto de Lafaille, M.A. & Lafaille, J.J. CD4+ regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14, 771–778 (2002).
Gavin, M. & Rudensky, A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr. Opin. Immunol. 15, 690–696 (2003).
Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345–352 (2005).
Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253–257 (2003).
Chen, W. et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003).
Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401–1408 (2004).
Curotto de Lafaille, M.A., Lino, A.C., Kutchukhidze, N. & Lafaille, J.J. CD25− T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173, 7259–7268 (2004).
Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923–1933 (2005).
Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219–1227 (2005).
Knoechel, B., Lohr, J., Kahn, E., Bluestone, J.A. & Abbas, A.K. Sequential development of interleukin-2–dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202, 1375–1386 (2005).
Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409–414 (2003).
Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 (1992).
Maclean, K.H., Keller, U.B., Rodriguez-Galindo, C., Nilsson, J.A. & Cleveland, J.L. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL . Mol. Cell. Biol. 23, 7256–7270 (2003).
Dansen, T.B., Whitfield, J., Rostker, F., Brown-Swigart, L. & Evan, G.I. Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo. J. Biol. Chem. 281, 10890–10895 (2006).
Soucie, E.L. et al. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol. Cell. Biol. 21, 4725–4736 (2001).
Juin, P. et al. c-Myc functionally cooperates with Bax to induce apoptosis. Mol. Cell. Biol. 22, 6158–6169 (2002).
Mitchell, K.O. et al. Bax is a transcriptional target and mediator of c-myc–induced apoptosis. Cancer Res. 60, 6318–6325 (2000).
Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775 (2007).
Powrie, F., Carlino, J., Leach, M.W., Mauze, S. & Coffman, R.L. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1–mediated colitis by CD45RBlow CD4+ T cells. J. Exp. Med. 183, 2669–2674 (1996).
Shen, S. et al. Control of homeostatic proliferation by regulatory T cells. J. Clin. Invest. 115, 3517–3526 (2005).
Curotto de Lafaille, M.A. et al. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J. Exp. Med. 194, 1349–1359 (2001).
Gounari, F. et al. Somatic activation of β-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development. Nat. Immunol. 2, 863–869 (2001).
Ioannidis, V., Beermann, F., Clevers, H. & Held, W. The β-catenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival. Nat. Immunol. 2, 691–697 (2001).
Ohteki, T. et al. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J. Exp. Med. 192, 99–104 (2000).
Staal, F.J. et al. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Eur. J. Immunol. 31, 285–293 (2001).
Mulroy, T., Xu, Y. & Sen, J.M. β-catenin expression enhances generation of mature thymocytes. Int. Immunol. 15, 1485–1494 (2003).
Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).
Lombardi, G., Sidhu, S., Batchelor, R. & Lechler, R. Anergic T cells as suppressor cells in vitro. Science 264, 1587–1589 (1994).
Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359–368 (2007).
Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375–387 (2006).
Acknowledgements
We thank D. Littman for comments, A. Rudensky for discussing unpublished data, M. Leung for the effector cytokine data in Supplementary Figure 3, H. Huo for assistance with the shRNA constructs and the transduction of TCR transgenic T cells, and T. Reya (Duke University Medical Center, Durham, NC) for the stable β-catenin and empty control vectors. S.S. is a recipient of a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. A.C.L. is a recipient of a predoctoral fellowship from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). Work in J.J.L.'s laboratory is funded by the National Institutes of Health/NIAID, and the National Multiple Sclerosis Society.
Author information
Authors and Affiliations
Contributions
Y.D. was involved in the execution of all experiments and the preparation of the manuscript. S.S. contributed to some of the in vivo experiments, A.C.L. contributed to some of the in vitro experiments and M.A.C.L. contributed to the experiments with the T/B monoclonal and T/B monoclonal Scurfy mouse lines. J.J.L. supervised the project and prepared the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1–4 and Supplementary Table 1 (PDF 333 kb)
Rights and permissions
About this article
Cite this article
Ding, Y., Shen, S., Lino, A. et al. Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat Med 14, 162–169 (2008). https://doi.org/10.1038/nm1707
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1707
This article is cited by
-
The cutting-edge progress of immune-checkpoint blockade in lung cancer
Cellular & Molecular Immunology (2021)
-
Informing the new developments and future of cancer immunotherapy
Cancer and Metastasis Reviews (2021)
-
Wnts and the hallmarks of cancer
Cancer and Metastasis Reviews (2020)
-
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro
Scientific Reports (2019)
-
Gimap5-dependent inactivation of GSK3β is required for CD4+ T cell homeostasis and prevention of immune pathology
Nature Communications (2018)